For research use only. Not for therapeutic Use.
Lorvotuzumab mertansine (IMGN901, LM) is an antibody-drug conjugate, linking an anti-mitotic agent (DM1) to an anti-CD56 antibody (lorvotuzumab).
| Catalog Number | I047336 |
| Purity | ≥95% |
| Reference | [1] Geller JI, et al. Cancer. 2020 Dec 15;126(24):5303-5310. |
